Fresenius Medical Care AG & Co. KGaA (0H9X) Share Forecast & Price Target

Compare

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0H9X Analyst Ratings

Hold

3 Buy

7 Hold

3 Sell

Based on 13 analysts giving stock ratings to

Fresenius

Medical Care AG & Co. KGaA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0H9X Stock 12 Month Forecast

Average Price Target

€50.23

▲(4.00%Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is €50.23 with a high forecast of €60.00 and a low forecast of €40.00. The average price target represents a 4.00% change from the last price of €48.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"32":"€32","61":"€61","39.25":"€39.3","46.5":"€46.5","53.75":"€53.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€60.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€50.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[32,39.25,46.5,53.75,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,50.4,51.138461538461534,51.87692307692308,52.61538461538461,53.353846153846156,54.09230769230769,54.83076923076923,55.56923076923077,56.30769230769231,57.04615384615384,57.784615384615385,58.52307692307692,59.261538461538464,{"y":60,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,50.4,50.386923076923075,50.37384615384615,50.36076923076923,50.347692307692306,50.33461538461538,50.32153846153846,50.308461538461536,50.29538461538461,50.28230769230769,50.26923076923077,50.25615384615384,50.24307692307692,{"y":50.23,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,50.4,49.6,48.8,48,47.199999999999996,46.4,45.6,44.8,44,43.2,42.4,41.6,40.8,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":38.08,"date":1717200000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":35.23,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":33.65,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":33.75,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":37.16,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":34.97,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":41.77,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":42.95,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":46.86,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":45,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":44.8,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":43.29,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":50.4,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€60.00

Average Price Target€50.23

Lowest Price Target€40.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Victoria LambertBerenberg Bank

Berenberg Bank

€55→€60

Buy

24.22%

Upside

Reiterated

06/24/25

Berenberg Bank Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Richard FeltonGoldman Sachs

Goldman Sachs

€60

Buy

24.22%

Upside

Reiterated

06/18/25

Goldman Sachs Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Julien OuaddourBank of America Securities

Bank of America Securities

€56

Hold

15.94%

Upside

Reiterated

06/18/25

Fresenius Medical Care: Hold Rating Amid Ambitious Targets and Execution Risks

Lisa Bedell CliveBernstein

Bernstein

€50→€54.5

Hold

12.84%

Upside

Reiterated

06/18/25

Bernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

David AdlingtonJ.P. Morgan

J.P. Morgan

€41.5

Sell

-14.08%

Downside

Reiterated

06/18/25

J.P. Morgan Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Graham DoyleUBS

UBS

€43.5

Hold

-9.94%

Downside

Reiterated

06/17/25

UBS Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

James VaneJefferies

Jefferies

€40

Sell

-17.18%

Downside

Reiterated

06/17/25

Jefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Oliver ReinbergKepler Capital

Kepler Capital

€49

Hold

1.45%

Upside

Reiterated

06/17/25

Kepler Capital Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Veronika DubajovaCiti

Citi

€46.5→€52.5

Hold

8.70%

Upside

Reiterated

06/05/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Citi

Hassan Al-WakeelBarclays

Barclays

€43→€51

Hold

5.59%

Upside

Reiterated

05/20/25

Barclays Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Robert DaviesMorgan Stanley

Morgan Stanley

€41→€43

Sell

-10.97%

Downside

Reiterated

05/15/25

Fresenius Medical price target raised to EUR 43 from EUR 41 at Morgan StanleyFresenius Medical price target raised to EUR 43 from EUR 41 at Morgan Stanley

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

05/12/25

Falko FriedrichsDeutsche Bank

Deutsche Bank

€45

Hold

-6.83%

Downside

Reiterated

05/06/25

Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Christian EhmannWarburg Research

Warburg Research

€43

Hold

-10.97%

Downside

Reiterated

02/25/25

Warburg Research Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Sezgi OezenerHSBC

HSBC

€37→€48

Buy

-0.62%

Downside

Upgraded

12/04/24

HSBC Upgrades Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) to BuyHSBC analyst Sezgi Oezener upgraded Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) from Hold to Buy with a price target of EUR48.00 (from EUR37.00).

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Victoria LambertBerenberg Bank

Berenberg Bank

€55→€60

Buy

24.22%

Upside

Reiterated

06/24/25

Berenberg Bank Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Richard FeltonGoldman Sachs

Goldman Sachs

€60

Buy

24.22%

Upside

Reiterated

06/18/25

Goldman Sachs Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Julien OuaddourBank of America Securities

Bank of America Securities

€56

Hold

15.94%

Upside

Reiterated

06/18/25

Fresenius Medical Care: Hold Rating Amid Ambitious Targets and Execution Risks

Lisa Bedell CliveBernstein

Bernstein

€50→€54.5

Hold

12.84%

Upside

Reiterated

06/18/25

Bernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

David AdlingtonJ.P. Morgan

J.P. Morgan

€41.5

Sell

-14.08%

Downside

Reiterated

06/18/25

J.P. Morgan Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Graham DoyleUBS

UBS

€43.5

Hold

-9.94%

Downside

Reiterated

06/17/25

UBS Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

James VaneJefferies

Jefferies

€40

Sell

-17.18%

Downside

Reiterated

06/17/25

Jefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Oliver ReinbergKepler Capital

Kepler Capital

€49

Hold

1.45%

Upside

Reiterated

06/17/25

Kepler Capital Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Veronika DubajovaCiti

Citi

€46.5→€52.5

Hold

8.70%

Upside

Reiterated

06/05/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Citi

Hassan Al-WakeelBarclays

Barclays

€43→€51

Hold

5.59%

Upside

Reiterated

05/20/25

Barclays Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Robert DaviesMorgan Stanley

Morgan Stanley

€41→€43

Sell

-10.97%

Downside

Reiterated

05/15/25

Fresenius Medical price target raised to EUR 43 from EUR 41 at Morgan StanleyFresenius Medical price target raised to EUR 43 from EUR 41 at Morgan Stanley

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

05/12/25

Falko FriedrichsDeutsche Bank

Deutsche Bank

€45

Hold

-6.83%

Downside

Reiterated

05/06/25

Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Christian EhmannWarburg Research

Warburg Research

€43

Hold

-10.97%

Downside

Reiterated

02/25/25

Warburg Research Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Sezgi OezenerHSBC

HSBC

€37→€48

Buy

-0.62%

Downside

Upgraded

12/04/24

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

1 Month

xxx

Success Rate

15/23 ratings generated profit

Average Return

+3.97%

reiterated a xxx

rating 6 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 65.22% of your transactions generating a profit, with an average return of +3.97% per trade.

3 Months

xxx

Success Rate

17/23 ratings generated profit

Average Return

+7.14%

reiterated a xxx

rating 6 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 73.91% of your transactions generating a profit, with an average return of +7.14% per trade.

1 Year

Victoria LambertBerenberg Bank

Success Rate

18/23 ratings generated profit

Average Return

+13.52%

reiterated a buy rating 6 days ago

Copying Victoria Lambert's trades and holding each position for 1 Year would result in 78.26% of your transactions generating a profit, with an average return of +13.52% per trade.

2 Years

xxx

Success Rate

22/23 ratings generated profit

Average Return

+27.47%

reiterated a xxx

rating 6 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 95.65% of your transactions generating a profit, with an average return of +27.47% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0H9X Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0H9X has received 10 Buy Ratings, 17 Hold Ratings, and 11 Sell Ratings. 0H9X average Analyst price target in the past 3 months is 50.23.

Each month's total comprises the sum of three months' worth of ratings.

0H9X Financial Forecast

0H9X Earnings Forecast

Next quarter’s earnings estimate for 0H9X is €0.86 with a range of €0.75 to €0.96. The previous quarter’s EPS was €0.84. 0H9X beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.16% of the time in the same period. In the last calendar year 0H9X has Outperformed its overall industry.

0H9X Sales Forecast

Next quarter’s sales forecast for 0H9X is €5.00B with a range of €4.65B to €5.92B. The previous quarter’s sales results were €4.88B. 0H9X beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year 0H9X has Outperformed its overall industry.

0H9X Stock Forecast FAQ

What is GB:0H9X’s average 12-month price target, according to analysts?

Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is 50.23.

What is GB:0H9X’s upside potential, based on the analysts’ average price target?

Fresenius Medical Care AG & Co. KGaA has 4.00% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?

Fresenius Medical Care AG & Co. KGaA has a consensus rating of Hold, which is based on 3 buy ratings, 7 hold ratings and 3 sell ratings.

What is Fresenius Medical Care AG & Co. KGaA’s share price target?

The average share price target for Fresenius Medical Care AG & Co. KGaA is 50.23. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €60.00 ,and the lowest forecast is €40.00. The average share price target represents 4.00% Increase from the current price of €48.3.

What do analysts say about Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Fresenius Medical Care AG & Co. KGaA?

To buy shares of GB:0H9X, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Fresenius Medical Care AG & Co. KGaA (0H9X) Share Forecast & Price Target

0H9X Analyst Ratings

0H9X Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

0H9X Analyst Recommendation Trends

0H9X Financial Forecast

0H9X Earnings Forecast

0H9X Sales Forecast

0H9X Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts